1. Home
  2. PGEN vs HURN Comparison

PGEN vs HURN Comparison

Compare PGEN & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.13

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

HOLD

Current Price

$162.68

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
HURN
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
PGEN
HURN
Price
$7.13
$162.68
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$8.33
$204.40
AVG Volume (30 Days)
6.0M
329.8K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
1.34
Revenue
$230,981,000.00
$1,699,143,000.00
Revenue This Year
$1,115.92
$11.80
Revenue Next Year
$81.04
$8.23
P/E Ratio
$248.00
$121.23
Revenue Growth
N/A
11.65
52 Week Low
$2.99
$84.88
52 Week High
$7.49
$186.78

Technical Indicators

Market Signals
Indicator
PGEN
HURN
Relative Strength Index (RSI) 62.70 68.26
Support Level $3.96 $158.12
Resistance Level $7.32 $172.67
Average True Range (ATR) 0.44 5.78
MACD 0.02 -0.26
Stochastic Oscillator 75.70 88.64

Price Performance

Historical Comparison
PGEN
HURN

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

Share on Social Networks: